Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis / 浙江大学学报（英文版）（B辑：生物医学和生物技术）

Polypyrimidine tract-binding protein 1 (PTBP1) plays an essential role in splicing and is expressed in almost all cell types in humans, unlike the other proteins of the PTBP family. PTBP1 mediates several cellular processes in certain types of cells, including the growth and differentiation of neuronal cells and activation of immune cells. Its function is regulated by various molecules, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA-binding proteins. PTBP1 plays roles in various diseases, particularly in some cancers, including colorectal cancer, renal cell cancer, breast cancer, and glioma. In cancers, it acts mainly as a regulator of glycolysis, apoptosis, proliferation, tumorigenesis, invasion, and migration. The role of PTBP1 in cancer has become a popular research topic in recent years, and this research has contributed greatly to the formulation of a useful therapeutic strategy for cancer. In this review, we summarize recent findings related to PTBP1 and discuss how it regulates the development of cancer cells.

effect of leptin on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in nude mice

To investigate the effect of leptin in the model of ectopic bone formation that utilizes subcutaneously implanted recombinant human bone morphogenetic protein-2 [rhBMP-2]-containing type I collagen discs. This study was performed in the Clinical Research Center, Southern Medical University, Guangzhou, China from November 2008 to June 2009. A single dose of 20 micro l saline [group A], 20 micro g leptin [group B], 2 micro g rhBMP-2 [group C], 2 micro g rhBMP-2 + 20 micro g leptin [group D], and type I collagen disks as a carrier were mixed, and subcutaneouly implanted into the back of nude mice [n=12]. The effect of ectopic bone formation was evaluated by radiography, dual energy X absorptiometry, biochemical examination of alkaline phosphatase [ALP] activity, histological observation, and semi-quantitative evaluation 4 and 8 weeks after surgery. At 4 and 8 weeks after operation the radiographs, bone mass density, ALP, and histology values showed significant intragroup and intergroup differences, with those at 8 weeks being higher than those at 4 weeks. Our results indicated that the sustainedly released material with collagen as a carrier combined treatment with leptin and rhBMP-2 has a very good osteoinductive activity. Leptin is a positive modulator for the osteoinductive efficacy of BMPs, they have synergistic effect. Its mechanisms are probably related to promote the formation of new-vessels and proliferation/ differentiation of many kinds of cells